Dataset Information


Pharmacogenomic assessment of Mexican and Peruvian populations.

ABSTRACT: Clinically relevant polymorphisms often demonstrate population-specific allele frequencies. Central and South America remain largely uncategorized in the context of pharmacogenomics.We assessed 15 polymorphisms from 12 genes (ABCB1 3435C>T, ABCG2 Q141K, CYP1B1*3, CYP2C19*2, CYP3A4*1B, CYP3A5*3C, ERCC1 N118N, ERCC2 K751Q, GSTP1 I105V, TPMT 238G>C, TPMT 460G>A, TPMT 719A>G, TYMS TSER, UGT1A1*28 and UGT1A1 -3156G>A) in 81 Peruvian and 95 Mexican individuals.Six polymorphism frequencies differed significantly between the two populations: ABCB1 3435C>T, CYP1B1*3, GSTP1 I105V, TPMT 460G>A, UGT1A1*28 and UGT1A1 -3156G>A. The pattern of observed allele frequencies for all polymorphisms could not be accurately estimated from any single previously studied population.This highlights the need to expand the scope of geographic data for use in pharmacogenomics studies.


PROVIDER: S-EPMC4515450 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7417535 | BioStudies
2007-01-01 | S-EPMC1876748 | BioStudies
2012-01-01 | S-EPMC6493375 | BioStudies
2015-01-01 | S-EPMC4345960 | BioStudies
1000-01-01 | S-EPMC5708903 | BioStudies
2020-01-01 | S-EPMC7739863 | BioStudies
2018-01-01 | S-EPMC6043481 | BioStudies
| S-EPMC7180851 | BioStudies
2012-01-01 | S-EPMC3292264 | BioStudies
2016-01-01 | S-EPMC5013326 | BioStudies